Verena Angerer

1.1k total citations
30 papers, 873 citations indexed

About

Verena Angerer is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Verena Angerer has authored 30 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Toxicology, 19 papers in Pharmacology and 14 papers in Clinical Psychology. Recurrent topics in Verena Angerer's work include Forensic Toxicology and Drug Analysis (27 papers), Cannabis and Cannabinoid Research (19 papers) and Psychedelics and Drug Studies (14 papers). Verena Angerer is often cited by papers focused on Forensic Toxicology and Drug Analysis (27 papers), Cannabis and Cannabinoid Research (19 papers) and Psychedelics and Drug Studies (14 papers). Verena Angerer collaborates with scholars based in Germany, Switzerland and Austria. Verena Angerer's co-authors include Volker Auwärter, Florian Franz, Bjoern Moosmann, Maren Hermanns‐Clausen, Ilkka Ojanperä, Melanie Hutter, Anna Pelander, Stefan Kneisel, Philippe Bisel and Jörg Pietsch and has published in prestigious journals such as Analytica Chimica Acta, Analytical and Bioanalytical Chemistry and Archives of Toxicology.

In The Last Decade

Verena Angerer

28 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Angerer Germany 18 751 515 269 217 180 30 873
Florian Franz Germany 20 808 1.1× 590 1.1× 279 1.0× 325 1.5× 181 1.0× 29 1.0k
Marisol S. Castaneto United States 16 902 1.2× 715 1.4× 289 1.1× 263 1.2× 258 1.4× 22 1.1k
Cornelius Heß Germany 16 513 0.7× 303 0.6× 161 0.6× 197 0.9× 151 0.8× 45 710
Kevin G. Shanks United States 12 644 0.9× 395 0.8× 259 1.0× 199 0.9× 115 0.6× 15 776
Bjoern Moosmann Germany 22 1.1k 1.5× 640 1.2× 438 1.6× 379 1.7× 266 1.5× 37 1.3k
Melanie Hutter Germany 13 484 0.6× 283 0.5× 186 0.7× 161 0.7× 145 0.8× 13 690
Cindy L. Moran United States 8 724 1.0× 612 1.2× 215 0.8× 239 1.1× 210 1.2× 8 818
Annelies Cannaert Belgium 22 856 1.1× 664 1.3× 298 1.1× 611 2.8× 71 0.4× 35 1.2k
Gregory W. Endres United States 9 528 0.7× 440 0.9× 148 0.6× 196 0.9× 149 0.8× 11 636
Stefan Kneisel Germany 18 1.4k 1.8× 1.1k 2.1× 448 1.7× 316 1.5× 450 2.5× 20 1.5k

Countries citing papers authored by Verena Angerer

Since Specialization
Citations

This map shows the geographic impact of Verena Angerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Angerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Angerer more than expected).

Fields of papers citing papers by Verena Angerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Angerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Angerer. The network helps show where Verena Angerer may publish in the future.

Co-authorship network of co-authors of Verena Angerer

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Angerer. A scholar is included among the top collaborators of Verena Angerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Angerer. Verena Angerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wenzel, Volker, et al.. (2024). Droplet Formation in Drugs During Extreme Temperature Conditions in the Emergency Medical Service, a Problem?. Air Medical Journal. 44(1). 114–116.
2.
3.
Roider, Gabriele, Verena Angerer, Jan Schäper, et al.. (2023). “Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014–2020). International Journal of Legal Medicine. 137(4). 1059–1069. 10 indexed citations
4.
Halter, Sebastian, Verena Angerer, Volker Auwärter, et al.. (2022). Effect of new legislation in Germany on prevalence and harm of synthetic cannabinoids. Clinical Toxicology. 60(10). 1130–1138. 4 indexed citations
5.
6.
7.
Hermanns‐Clausen, Maren, Dieter Müller, Verena Angerer, et al.. (2017). Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicology. 56(6). 404–411. 54 indexed citations
8.
Angerer, Verena, et al.. (2017). Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA. Forensic Science International. 281. e9–e15. 80 indexed citations
9.
Franz, Florian, Verena Angerer, Christian Schlögl, et al.. (2017). Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 55(9). 1375–1384. 45 indexed citations
10.
Mogler, Lukas, Florian Franz, Daniel Rentsch, et al.. (2017). Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples. Drug Testing and Analysis. 10(1). 196–205. 87 indexed citations
11.
Hermanns‐Clausen, Maren, et al.. (2017). Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus. Clinical Toxicology. 55(8). 922–924. 18 indexed citations
12.
Angerer, Verena, Philippe Bisel, Bjoern Moosmann, Folker Westphal, & Volker Auwärter. (2016). Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative NE-CHMIMO using flash chromatography, GC-MS, IR and NMR spectroscopy. Forensic Science International. 266. e93–e98. 22 indexed citations
13.
Franz, Florian, Verena Angerer, Maren Hermanns‐Clausen, Volker Auwärter, & Bjoern Moosmann. (2016). Metabolites of synthetic cannabinoids in hair—proof of consumption or false friends for interpretation?. Analytical and Bioanalytical Chemistry. 408(13). 3445–3452. 48 indexed citations
14.
Ferk, Franziska, Richard Gminski, Miroslav Mišík, et al.. (2016). Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4. Archives of Toxicology. 90(12). 3111–3123. 19 indexed citations
15.
Angerer, Verena, et al.. (2016). Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project. Drug Testing and Analysis. 8(10). 1030–1038. 41 indexed citations
16.
Müller, Dieter, et al.. (2016). Desoxypipradrol – eine neue (alte) Designerdroge. DMW - Deutsche Medizinische Wochenschrift. 141(13). 951–953.
17.
Ferk, Franziska, Verena Angerer, Miroslav Mišík, et al.. (2016). Investigations of the genotoxic properties of two synthetic cathinones (3-MMC, 4-MEC) which are used as psychoactive drugs. Toxicology Research. 5(5). 1410–1420. 6 indexed citations
18.
Vogt, Susanne, et al.. (2015). Analysis of 'poppers' products and analytical detectability of a single use of 'poppers'. FreiDok plus (Universitätsbibliothek Freiburg). 3 indexed citations
19.
Moosmann, Bjoern, et al.. (2014). Hair analysis of synthetic cannabinoids: does the handling of herbal mixtures affect the analyst’s hair concentration?. Forensic Toxicology. 33(1). 37–44. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Franz Breakdown of academic impact, for papers by Marisol S. Castaneto Breakdown of academic impact, for papers by Cornelius Heß Breakdown of academic impact, for papers by Kevin G. Shanks Breakdown of academic impact, for papers by Bjoern Moosmann Breakdown of academic impact, for papers by Melanie Hutter Breakdown of academic impact, for papers by Cindy L. Moran Breakdown of academic impact, for papers by Annelies Cannaert Breakdown of academic impact, for papers by Gregory W. Endres Breakdown of academic impact, for papers by Stefan Kneisel
Rankless by CCL
2026